IPO Year: 2021
Exchange: NASDAQ
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 1/18/2022 | $6.00 | Buy | EF Hutton |
4 - G Medical Innovations Holdings Ltd. (0001760764) (Issuer)
3 - G Medical Innovations Holdings Ltd. (0001760764) (Issuer)
EF Hutton initiated coverage of G Medical Innovations with a rating of Buy and set a new price target of $6.00
SC 13D/A - G Medical Innovations Holdings Ltd. (0001760764) (Subject)
SC 13D/A - G Medical Innovations Holdings Ltd. (0001760764) (Subject)
SC 13D/A - G Medical Innovations Holdings Ltd. (0001760764) (Subject)
SC 13G/A - G Medical Innovations Holdings Ltd. (0001760764) (Subject)
SC 13G/A - G Medical Innovations Holdings Ltd. (0001760764) (Subject)
SC 13G/A - G Medical Innovations Holdings Ltd. (0001760764) (Subject)
SC 13D/A - G Medical Innovations Holdings Ltd. (0001760764) (Subject)
SC 13G - G Medical Innovations Holdings Ltd. (0001760764) (Subject)
SC 13G - G Medical Innovations Holdings Ltd. (0001760764) (Subject)
SC 13D - G Medical Innovations Holdings Ltd. (0001760764) (Subject)
Irvine, CA, Nov. 18, 2022 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (NASDAQ:GMVD) ("G Medical" or the "Company"), an early commercial stage healthcare company engaged in the development of next generation mHealth and telemedicine solutions and monitoring service platforms, today announced its financial results and provided a business update for the six months ended June 30, 2022. First Half 2022 Financial Results During the six months period ended June 30, 2022, the Company performed over 100,000 tests which includes four types of diagnostic tests –Rapid Antigen, A/B Flu, PCR and Antibody; in connection with these tests, the Company expects to submit approximately
6-K - G Medical Innovations Holdings Ltd. (0001760764) (Filer)
6-K - G Medical Innovations Holdings Ltd. (0001760764) (Filer)
D - G Medical Innovations Holdings Ltd. (0001760764) (Filer)
25-NSE - G Medical Innovations Holdings Ltd. (0001760764) (Subject)
6-K - G Medical Innovations Holdings Ltd. (0001760764) (Filer)
6-K - G Medical Innovations Holdings Ltd. (0001760764) (Filer)
6-K - G Medical Innovations Holdings Ltd. (0001760764) (Filer)
6-K - G Medical Innovations Holdings Ltd. (0001760764) (Filer)
6-K - G Medical Innovations Holdings Ltd. (0001760764) (Filer)
6-K - G Medical Innovations Holdings Ltd. (0001760764) (Filer)
Rehovot, Israel, Aug. 17, 2023 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (NASDAQ:GMVD) ("G Medical Innovations"), an industry innovator in comprehensive remote patient monitoring solutions, today announced that its wholly-owned subsidiary, G Medical Innovations USA, Inc., has entered into an agreement with Resilient Support Services Inc. ("RSS") to expand the health care and remote patient monitoring capabilities to U.S. veterans and military personnel. RSS is a Service-Disabled Veteran-Owned Business that partners with U.S. federal agencies and private sector businesses that are concerned with improving the medical care of veterans and the military community. G Medi
Rehovot, Israel, Aug. 07, 2023 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (NASDAQ:GMVD) ("G Medical Innovations" or the "Company"), a global leader in next-generation mobile health (mHealth) and digital health, today issued the following update to shareholders from President and CEO Dr. Yacov Geva. Dear Fellow Shareholders, We are proud to report that at this halfway point of 2023, G Medical has met several significant milestones and is on track to show revenue growth and gain profitability. Our Company has experienced growth in its monitoring services, and we are getting ready to add revenue with our "At Home Test Kits" business unit as we are no
Rehovot, Israel, May 19, 2023 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (NASDAQ:GMVD) (the "Company"), a telehealth, medical device, and remote patient monitoring company, announced today that on May 15, 2023 it received a written notice (the "Notice") from Nasdaq Stock Market LLC, indicating that the Company is not in compliance with the minimum bid price requirement for continued listing set forth in Nasdaq Listing Rule 5550(a)(2), which requires listed securities to maintain a minimum bid price of $1.00 per share. Under Nasdaq Listing Rule 5810(c)(3)(A), the Company has been granted a period of 180 calendar days to regain compliance with the minimum bid price requirement.
Rehovot, Israel, May 15, 2023 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (NASDAQ:GMVD) (the "Company") announced today that, on May 11, 2023, the Company received notice from the Hearings Panel (the "Panel") of the Nasdaq Stock Market LLC ("Nasdaq") that the Panel has granted the request of the Company to continue its listing on Nasdaq, subject to the conditions described below. As previously disclosed by the Company, on November 22, 2022, the Company received a deficiency letter from the Listing Qualifications Department of the Nasdaq notifying it that, based on its shareholders' deficit of $1,240 thousand as of June 30, 2022, as reported in the Company's Report of Forei
Rehovot, Israel, April 18, 2023 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (NASDAQ:GMVD) (the "Company" or "G Medical"), a global leader in next-generation mobile health (mHealth) and digital health, is excited to report that patient enrollment has grown in its home monitoring services by 194% between January and April of 2023, as compared to the same period last year. The increase is due to growing demand for homecare monitoring. As previously announced, in the first quarter of 2023, G Medical signed an agreement with AdventHealth of Central Florida ("AdventHealth"), an operator of 20 hospitals and emergency rooms. AdventHealth experiences on average 5.7 million patient visi
Rehovot, Israel, April 04, 2023 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (NASDAQ:GMVD) (the "Company"), a global leader in next-generation mobile health (mHealth) and digital health, today announced the closing of its public offering of 12,000,000 ordinary shares (or pre-funded warrants ("Pre-Funded Warrants") in lieu thereof), each sold to the public at a price of $0.80 (inclusive of the exercise price of the Pre-Funded Warrant) for gross proceeds of approximately $9.6 million, before deducting underwriting discounts and offering expenses. In addition, the Company has granted the underwriters a 45-day option to purchase up to an additional 1,800,000 ordinary shares and/or P
Rehovot, Israel, March 31, 2023 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (NASDAQ:GMVD) (the "Company"), a global leader in next-generation mobile health (mHealth) and digital health, today announced the pricing of an underwritten public offering of 12,000,000 ordinary shares (or pre-funded warrants ("Pre-Funded Warrants") in lieu thereof). Each ordinary share (or Pre-Funded Warrant) is being sold to the public at a price of $0.80 (inclusive of the exercise price of the Pre-Funded Warrant) for gross proceeds of approximately $9.6 million, before deducting underwriting discounts and offering expenses. In addition, the Company has granted the underwriters a 45-day option to pu
Rehovot, Israel, March 29, 2023 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (NASDAQ:GMVD) (the "Company" or "G Medical Innovations"), a global leader in next-generation mobile health (mHealth) and digital health, today announced that its wholly-owned subsidiary, G Medical Innovations USA, Inc., has entered into an agreement with AdventHealth Central Florida ("AdventHealth") to expand the health care system's remote patient monitoring capabilities. Pursuant to the agreement, G Medical Innovations will provide devices to AdventHealth for remote patient monitoring (using the Company's Prizma device), mobile cardiac telemetry (MCT) and extended holter (AECG) monitoring for AdventH
Rehovot, Israel, March 27, 2023 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (NASDAQ:GMVD) (the "Company" or "G Medical Innovations"), a global leader in next-generation mobile health (mHealth) and digital health, and MiCare Path, a leader in optimized patient care through remote patient monitoring, today announced a collaboration to incorporate MiCare Path's solutions and G Medical Innovations' solutions. As part of the collaboration, G Medical Innovations' hardware devices will be integrated with MiCare's software platform and visualization tools to provide remote patient monitoring services. The partnership brings together two innovative companies with a shared vision of tra
Rehovot, Israel, Feb. 17, 2023 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (NASDAQ:GMVD) (the "Company") announced today that on February 16, 2023, the Company received notice from the Listing Qualifications Department (the "Staff") of The Nasdaq Stock Market LLC ("Nasdaq") that, based upon the Company's non-compliance with the stockholders' equity requirement for continued listing on The Nasdaq Capital Market, as set forth in Nasdaq Listing Rule 5550(b) (the "Equity Rule"), the Company is subject to delisting from Nasdaq unless the Company timely requests a hearing before a Nasdaq Hearings Panel (the "Panel"). Accordingly, the Company plans to timely request a hearing before
-SEC filing
Gainers Enhabit (NYSE:EHAB) stock increased by 8.2% to $12.92 during Wednesday's after-market session. The company's market cap stands at $647.3 million. Scilex Holding (NASDAQ:SCLX) stock increased by 7.76% to $3.33. The company's market cap stands at $496.3 million. Bullfrog AI Hldgs (NASDAQ:BFRG) stock increased by 7.59% to $3.54. Bullfrog AI Hldgs's trading volume hit 51.3K shares by close, accounting for 4.2% of its average volume over the last 100 days. The company's market cap stands at $21.5 million. Nemaura Medical (NASDAQ:NMRD) stock moved upwards by 7.31% to $0.44. The company's market cap stands at $12.7 million. NightHawk Biosciences (AMEX:NHWK) stock rose 6.25% to $0.68. T
Gainers GRI Bio (NASDAQ:GRI) stock increased by 65.7% to $4.44 during Wednesday's pre-market session. The market value of their outstanding shares is at $13.1 million. ITeos Therapeutics (NASDAQ:ITOS) shares increased by 41.19% to $16.59. The company's market cap stands at $593.6 million. Arcus Biosciences (NYSE:RCUS) stock increased by 35.72% to $25.53. The company's market cap stands at $1.9 billion. Apellis Pharmaceuticals (NASDAQ:APLS) shares increased by 26.46% to $38.9. The market value of their outstanding shares is at $4.5 billion. Kiora Pharmaceuticals (NASDAQ:KPRX) shares moved upwards by 19.64% to $0.61. The company's market cap stands at $4.4 million. Vaccinex (NASDAQ:VCNX)
Gainers Fulcrum Therapeutics, Inc. (NASDAQ:FULC) shares jumped 42.8% to $5.60 after the FDA lifted clinical hold on the company’s FTX-6058 for sickle cell disease. VinFast Auto Ltd. (NASDAQ:VFS) gained 42% to $24.96. Axcella Health Inc. (NASDAQ:AXLA) shares climbed 37.3% to $0.2101 after gaining 12% on Monday. The company recently posted a narrower-than-expected quarterly loss. Sidus Space, Inc. (NASDAQ:SIDU) shares gained 30.4% to $0.2101. Sidus Space acquired edge artificial intelligence company, Exo-Space. BioNexus Gene Lab Corp. (NASDAQ:BGLC) jumped 28.3% to $1.35. Fabrinet (NYSE:FN) gained 25% to $146.01 after the company reported better-than-expected fourth-quarter financial
Gainers Axcella Health (NASDAQ:AXLA) shares increased by 59.1% to $0.28 during Tuesday's pre-market session. The company's market cap stands at $20.5 million. Fulcrum Therapeutics (NASDAQ:FULC) stock increased by 35.45% to $5.31. The company's market cap stands at $328.2 million. G Medical Innovations (NASDAQ:GMVD) shares rose 32.12% to $0.21. The market value of their outstanding shares is at $2.0 million. Novo Integrated Sciences (NASDAQ:NVOS) shares rose 19.35% to $0.21. The market value of their outstanding shares is at $31.4 million. Matinas BioPharma Hldgs (AMEX:MTNB) shares rose 15.79% to $0.19. The company's market cap stands at $41.2 million. OpGen (NASDAQ:OPGN) shares rose 15
Gainers Axcella Health Inc. (NASDAQ:AXLA) shares gained 65% to $0.2887 in pre-market trading after gaining 12% on Monday. The company recently posted a narrower-than-expected quarterly loss. ProMIS Neurosciences, Inc. (NASDAQ:PMN) shares surged 32.9% to $2.10 in pre-market trading. ProMIS Neurosciences announced a $20.4 million private placement financing at $1.88 per unit. G Medical Innovations Holdings Ltd (NASDAQ:GMVD) rose 26.4% to $0.1995 in pre-market trading. Freight Technologies, Inc. (NASDAQ:FRGT) rose 22.1% to $0.6094 in pre-market trading after gaining around 4% on Monday. Hallmark Financial Services, Inc. (NASDAQ:HALL) shares rose 21.8% to $3.57 in pre-market trading. Ha
Gainers China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) shares gained 53.3% to $0.23 in pre-market trading. Tian Ruixiang Holdings Ltd (NASDAQ:TIRX) shares surged 37.1% to $1.48 in pre-market trading. Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) shares rose 26.3% to $4.31 in pre-market trading after gaining over 4% on Friday. Neptune Wellness Solutions Inc. (NASDAQ:NEPT) rose 22.1% to $0.2955 in pre-market trading. Neptune Wellness Solutions shares jumped 75% on Friday after the company reported first-quarter results and entered into a binding term sheet with Morgan Stanley providing the option to exchange the existing debt of Sprout Organics. The Growth for Good Acquisition Corporation (
Gainers PhenomeX Inc. (NASDAQ:CELL) shares surged 138.3% to $0.9532. Bruker Corporation and PhenomeX reported a $108 million definitive agreement for Bruker to acquire PhenomeX in an all-cash transaction for $1 per share. Tivic Health Systems, Inc. (NASDAQ:TIVC) shares jumped 39.1% to $0.0932. Tivic Health Systems shares jumped 80% on Wednesday after the company announced its funded study started enrollment for its non-invasive bioelectronic device approach to vagus nerve stimulation. Sunlight Financial Holdings Inc. (NYSE:SUNL) climbed 36.9% to $0.2101 after declining 8% on Wednesday. Advanced Health Intelligence Ltd. (NASDAQ:AHI) shares rose 30.2% to $5.00. Advanced Health Intelligen
Gainers Novo Integrated Sciences (NASDAQ:NVOS) stock increased by 68.6% to $0.2 during Wednesday's regular session. Trading volume for this security as of 13:31 EST is 346.2 million, which is 3787.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $29.0 million. Tivic Health Systems (NASDAQ:TIVC) stock increased by 59.13% to $0.06. As of 13:31 EST, this security is trading at a volume of 226.3 million shares, making up 1191.2% of its average full-day volume over the last 100 days. The company's market cap stands at $8.6 million. The company's, Q2 earnings came out 2 days ago. Navidea Biopharmaceutical (AMEX:NAVB) stock increased by
Gainers Novo Integrated Sciences, Inc. (NASDAQ:NVOS) shares climbed 94.8% to $0.2260 in pre-market trading. Novo Integrated Sciences issued an update on certain current actions and events. The company recently reported a year-over-year increase in third-quarter EPS results. Akumin Inc. (NASDAQ:AKU) shares jumped 61.3% to $0.2210. Akumin recently reported a year-over-year decrease in second-quarter financial results. Green Giant Inc. (NASDAQ:GGE) surged 55.2% to $1.49. EBET, Inc. (NASDAQ:EBET) climbed 53.7% to $0.0638 after jumping 22% on Tuesday. JX Luxventure Limited (NASDAQ:JXJT) gained 43.2% to $2.22 after reporting a profit for the six months ended June 30, 2023. Eightco Holding